At 26 weeks after treatment, the weight loss was -2.29 0.24 kg for 1.5 mg DUL, -1.36 0.24 kg for 0.75 mg DUL, and -2.22 0.24 kg for metformin (110)
Will my insurance continue covering it
Six participants were included in the ITT but excluded from the per-protocol (PP) analysis because they did not satisfy the definition of full adherence and therefore did not meet the conditions to be included in PP analysis
Persistent palpitations, chest discomfort, fainting, or severe lightheadedness should be medically evaluated
Patients taking weight loss drugs, including GLP-1 medications, need to be seen and monitored on a frequent basis
Stress-Related Skin Issues: Thiotres Tablet may assist in managing skin conditions that are linked to stress and fatigue